Pharmaceutical manufacturer
Pharmaceutical manufacturer remedies laborious review
Corporation cuts review by 70 percent with OpenText Insight Predict’s continuous active learning
The client’s approval to use TAR came only after the law firm had manually reviewed nearly half the collection. Even that late in the game, Insight Predict produced substantial savings in time and cost.
Challenge
- Faced claim of patent infringement
- Started review due to looming deadlines
- Progressed half-way through process before TAR approval
Product(s)
Value
- Leveraged completed work as seed set to train the TAR algorithm
- Reduced remaining review time by 70% with continuous active learning
- Saved nearly $70,000 after accounting for cost of TAR